血压控制药物血管紧张素转化酶抑制剂(acei)可以降低血压，并减少蛋白质从尿中的排泄。
Blood pressure medications. Drugs called angiotensin-converting enzyme inhibitors reduce blood pressure and also reduce the amount of protein released in urine.
血管紧张素转化酶(ace)抑制剂。
目的：探讨应用血管紧张素转化酶抑制剂(acei)治疗心血管疾病时引起急性肾衰竭和高钾血症的原因及其应对方法。
OBJECTIVE: To study the reasons for acute renal failure (ARF) and hyperkalemia caused by ACEI which is used for treating cardiovascular disease, and the dealing method.
目的探讨血管紧张素转化酶(ace)基因缺失多态性与中国人脑梗死、高血压性脑出血的关系。
Objective To investigate the relationship between the angiotensin converting enzyme (ACE) gene deletion polymorphism and cerebral infarction, hypertensive cerebral hemorrhage in Chinese.
血管紧张素转化酶抑制剂是治疗高血压和心脏衰竭的一种治疗方式。
ACE inhibitors are a type of medication used to treat high blood pressure and heart failure.
详尽阐述了具有降血压作用的血管紧张素转化酶抑制肽的食物来源、制备、酶法加工工艺流程及其前景展望。
Presening the food resource, preparation and technics line of enzymatic method of angiotensin converting enzyme inhibitory peptides which has antihypertensive function and predicting its perspective.
对第二代血管紧张素转化酶抑制剂依那普利的药理作用及临床应用作一简要综述。
The purest of the writing is to summarize the pharmacal effect and clinical practice of the second angiotensin - converting enzyme inhibitors enalapril.
目的探讨雌激素替代疗法（ERT）对绝经后妇女血清血管紧张素转化酶（ACE）含量及血脂代谢的影响。
Objective To investigate the effect of estrogen replacement therapy (ERT) on serum angiotensin-converting-enzyme(ACE) levels and lipids metabolism in postmenopausal women(PMW).
报道一种用反相hplc技术简便、有效地研究心血管紧张素转化酶抑制剂体外抑制动力学的新方法。
A simple reversed_phase HPLC method for the study of in_vitro inhibition kinetics of angiotensin_converting enzyme inhibitors is described.
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
近年来，许多学者对血管紧张素转化酶抑制剂抑制率的测定方法开展了大量的研究工作。
A lot of research work has been carried out about the analytical method for inhibitory activity of the angiotensin-converting enzyme in recent years.
目的观察血管紧张素转化酶抑制药卡托普利对大鼠局灶性脑缺血再灌注损伤后炎症反应的影响。
Purpose to investigate the anti-inflammatory effect of angiotensin-converting enzyme inhibitor captopril on the brain against ischemia-reperfusion injury and explore its mechanism of action.
目的探讨凋亡基因对大鼠心肌梗死的表达及血管紧张素转化酶抑制剂(acei)的干预作用。
Objective to investigate the expression of apoptosis - related genes in rats with myocardial infarction and effects of ACEI.
目的：研究鄂温克族血管紧张素转化酶(ace)基因多态性。
Objective: To analyse the polymorphism of ACE gene in Ewenki.
肾脏疾病曾经是90%硬皮病相关死亡的致死因素，直到上世纪八十年代一种被称为血管紧张素转化酶(ace)抑制剂的降压药物问世。
Kidney disease used to cause 90 percent of scleroderma-related deaths until the advent of a class of blood pressure drugs called angiotensin-converting enzyme, or ACE, inhibitors in the 1980s.
目的：研究血管紧张素转化酶抑制剂（ACEI）苯那普利对原发性高血压（EH）患者肾功能储备（RFR）的影响。
Objective: To study the effects of benazepril(ACEI) on renal functional reserve(RFR) of patients with essential hypertension (EH).
给清醒狗注射灵杆菌内毒素，观察血清和肺组织匀浆血管紧张素转化酶（ACE）活性的变化。
The effect of endotoxin on serum activity of angiotensin converting enzyme (ACE)in dogs was studied.
目的建立血管紧张素转化酶(ace)底物的合成方法，探讨血清ace活性的测定方法。
Objective To establish the synthetic method of the substrate for angiotensin-converting enzyme (ACE), and investigate the assay method of serum ACE.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
肾病综合症_第7张图片血压控制药物血管紧张素转化酶抑制剂(acei)可以降低血压，并减少蛋白质从尿中的排泄。
Blood pressure medications. Drugs called angiotensin-converting enzyme inhibitors reduce blood pressure and also reduce the amount of protein released in urine.
结果发现，陈旧性心肌梗死患者胰岛素抵抗水平和缺失型血管紧张素转化酶基因频率较对照组无统计学差异（P＞0．05）。
Results The insulin resistance level did not increase significantally in patients with old myocardial infarction, compared with control subjects(P>0.05);
结果钙拮抗剂、肾上腺素受体阻滞药、血管紧张素转化酶抑制剂(acei)在用药金额、用药频度上分别占前三位。
Results the amount used DDDs of calcium antagonists, adrenergic receptor blockers and ACEI drugs were the head of three.
结果钙拮抗剂、肾上腺素受体阻滞药、血管紧张素转化酶抑制剂(acei)在用药金额、用药频度上分别占前三位。
Results the amount used DDDs of calcium antagonists, adrenergic receptor blockers and ACEI drugs were the head of three.
应用推荐